Absci: Funding, Investors & Team (Oct 2026)
Absci is a company utilizing AI and synthetic biology to enhance the therapeutic possibilities of proteins. Our Integrated Drug Creation™ Platform streamlines the process of identifying drug targets, discovering biotherapeutic candidates, and manufacturing them. Biotech and pharma companies collaborate with us to create innovative protein-based drugs, such as Bionic Proteins™ with nonstandard amino acids, that may be difficult to produce using traditional methods. Our aim is to facilitate the development of improved medications by turning concepts into drugs. Visit www.absci.com for additional details.
Absci has raised $370M across 5 funding rounds on record, the most recent an undisclosed round of $100M announced in Jun 2026.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Absci Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Absci Funding Rounds
Absci raised $125M in an undisclosed round announced in Mar 2021.
2.9 years later, an undisclosed round of $75.2M was announced in Feb 2024.
11 months later, an undisclosed round of $20.0M was announced in Jan 2025.
6 months later, an undisclosed round of $50.0M was announced in Jul 2025.
11 months later, an undisclosed round of $100M was announced in Jun 2026.
Absci Founders and Leadership Team
Contact details for the Absci team: 1 of 1 has an email address on file.
Start 14-day free trial →Absci Funding Compared to Other Artificial Intelligence Startups
Absci's latest round of $100M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Absci in Artificial Intelligence and Vancouver
Companies Similar to Absci
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
Absci Funding FAQs
What does Absci do?
Absci is a company utilizing AI and synthetic biology to enhance the therapeutic possibilities of proteins. Our Integrated Drug Creation™ Platform streamlines the process of identifying drug targets, discovering biotherapeutic candidates, and manufacturing them. Biotech and pharma companies collaborate with us to create innovative protein-based drugs, such as Bionic Proteins™ with nonstandard amino acids, that may be difficult to produce using traditional methods. Our aim is to facilitate the development of improved medications by turning concepts into drugs. Visit www.absci.com for additional details.
How much funding has Absci raised?
Absci has raised $370M across 5 rounds on record. The most recent is an undisclosed round of $100M announced in Jun 2026.
When did Absci last raise funding?
Absci's most recent funding round on record is an undisclosed round of $100M, announced in Jun 2026.
Who founded Absci?
FundedIQ lists Sean Mcclain (Founder) at Absci.
Where is Absci headquartered?
Absci is based in Vancouver, Washington, United States.
How many employees does Absci have?
Absci is in the 101-250 employee band.
How does Absci's funding compare to other Artificial Intelligence startups?
Absci's latest round of $100M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's Absci Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Absci is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.